Role of tissue transglutaminase in GTP depletion-induced apoptosis of insulin-secreting (HIT-T15) cells

Biochemical Pharmacology

Volumn 66, Issue 2, 2003, Pages 213-223

  Huo, JianXin ^a   Metz, Stewart A ^b   Li, GuoDong ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b PACIFIC NORTHWEST RESEARCH INSTITUTE   (United States)

Author keywords

Apoptosis; Caspase; Guanine nucleotides; Islet cells; Mycophenolic acid; Tissue transglutaminase

Indexed keywords

ADENOSINE; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CALCIUM; CALCIUM ION; CASPASE; CASPASE INHIBITOR; DANSYLCADAVERINE; ENZYME; ENZYME INHIBITOR; GUANOSINE; GUANOSINE TRIPHOSPHATE; INSULIN; MYCOPHENOLIC ACID; PROTEIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PUTRESCINE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CELL ASSAY; CELL DEATH; CELL LINE; CELL STRUCTURE; CONCENTRATION (PARAMETERS); CULTURE MEDIUM; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME ASSAY; INSULIN RELEASE; MORPHOLOGICAL TRAIT; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; STRUCTURE ANALYSIS; TIME;

EID: 0037756827     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(03)00262-4     Document Type: Article

References (66)

1. Wyllie A.H., Kerr J.F., Currie A.R. Cell death: the significance of apoptosis. Int. Rev. Cytol. 68:1980;251-306.
2. Li G.D., Segu V.B., Rabaglia M.E., Luo R.H., Kowluru A., Metz S.A. Prolonged depletion of guanosine triphosphate induces death of insulin- secreting cells by apoptosis. Endocrinology. 139:1998;3752-3762.
3. Green D.R., Reed J.C. Mitochondria and apoptosis. Science. 281:1998;1309-1312.
4. Budihardjo I., Oliver H., Lutter M., Luo X., Wang X. Biochemical pathways of caspase activation during apoptosis. Annu. Rev. Cell Dev. Biol. 15:1999;269-290.
5. Fesus L., Thomazy V. Searching for the function of tissue transglutaminase: its possible involvement in the biochemical pathway of programmed cell death. Adv. Exp. Med. Biol. 231:1988;119-134.
6. Fesus L. Transglutaminase-catalyzed protein cross-linking in the molecular program of apoptosis and its relationship to neuronal processes. Cell Mol. Neurobiol. 18:1998;683-694.
7. Melino G., Piacentini M. 'Tissue' transglutaminase in cell death: a downstream or a multifunctional upstream effector? FEBS Lett. 430:1998;59-63.
8. Autuori F., Farrace M.G., Oliverio S., Piredda L., Piacentini M. 'Tissue' transglutaminase and apoptosis. Adv. Biochem. Eng. Biotechnol. 62:1998;129-136.
9. Melino G., Thiele C.J., Knight R.A., Piacentini M. Retinoids and the control of growth/death decisions in human neuroblastoma cell lines. J. Neurooncol. 31:1997;65-83.
10. Folk J.E. Transglutaminases. Annu. Rev. Biochem. 49:1980;517-531.
11. Aeschlimann D., Koeller M.K., Allen-Hoffmann B.L., Mosher D.F. Isolation of a cDNA encoding a novel member of the transglutaminase gene family from human keratinocytes. Detection and identification of transglutaminase gene products based on reverse transcription-polymerase chain reaction with degenerate primers. J. Biol. Chem. 273:1998;3452-3460.
12. Greenberg C.S., Birckbichler P.J., Rice R.H. Transglutaminases: multifunctional cross-linking enzymes that stabilize tissues. FASEB J. 5:1991;3071-3077.
13. Bungay P.J., Potter J.M., Griffin M. The inhibition of glucose-stimulated insulin secretion by primary amines. A role for transglutaminase in the secretory mechanism. Biochem. J. 219:1984;819-827.
14. Gomis R., Arbos M.A., Sener A., Malaisse W.J. Glucose-induced activation of transglutaminase in pancreatic islets. Diabetes Res. 3:1986;115-117.
15. Im M.J., Russell M.A., Feng J.F. Transglutaminase II: a new class of GTP-binding protein with new biological functions. Cell Signal. 9:1997;477-482.
16. 2+ and nucleotides. Biochem. J. 313:1996;803-808.
17. Zhang J., Lesort M., Guttmann R.P., Johnson G.V. Modulation of the in situ activity of tissue transglutaminase by calcium and GTP. J. Biol. Chem. 273:1998;2288-2295.
18. Lai T.S., Bielawska A., Peoples K.A., Hannun Y.A., Greenberg C.S. Sphingosylphosphocholine reduces the calcium ion requirement for activating tissue transglutaminase. J. Biol. Chem. 272:1997;16295-16300.
19. Bernassola F., Rossi A., Melino G. Regulation of transglutaminases by nitric oxide. Ann. N.Y. Acad. Sci. 887:1999;83-91.
20. Jayaram H.N., Cooney D.A., Grusch M. Consequences of IMP dehydrogenase inhibition, and its relationship to cancer and apoptosis. Curr. Med. Chem. 6:1999;561-574.
21. Metz S.A., Kowluru A. Inosine monophosphate dehydrogenase: a molecular switch integrating pleiotropic GTP-dependent beta-cell functions. Proc. Assoc. Am. Physicians. 111:1999;335-346.
22. Metz S.A., Holland S., Johnson L., Espling E., Rabaglia M., Segu V.B., Brockenbrough J.S., Tran P.O. Inosine-5′-monophosphate dehydrogenase is required for mitogenic competence of transformed pancreatic β cells. Endocrinology. 142:2001;193-204.
23. Cohn R.G., Mirkovich A., Dunlap B., Burton P., Chiu S.H., Eugui E., Caulfield J.P. Mycophenolic acid increases apoptosis, lysosomes and lipid droplets in human lymphoid and monocytic cell lines. Transplantation. 68:1999;411-418.
24. Catapano C.V., Dayton J.S., Mitchell B.S., Fernandes D.J. GTP depletion induced by IMP dehydrogenase inhibitors blocks RNA-primed DNA synthesis. Mol. Pharmacol. 47:1995;948-955.
25. Halloran P.F. Molecular mechanisms of new immunosuppressants. Clin. Transplant. 10:1996;118-123.
26. Franchetti P., Grifantini M. Nucleoside and non-nucleoside IMP dehydrogenase inhibitors as antitumor and antiviral agents. Curr. Med. Chem. 6:1999;599-614.
27. Huo J., Luo R.H., Metz S.A., Li G. Activation of caspase-2 mediates the apoptosis induced by GTP-depletion in insulin-secreting (HIT-T15) cells. Endocrinology. 143:2002;1695-1704.
28. Segu V.B., Li G., Metz S.A. Use of a soluble tetrazolium compound to assay metabolic activation of intact beta cells. Metabolism. 47:1998;824-830.
29. Buttke T.M., McCubrey J.A., Owen T.C. Use of an aqueous soluble tetrazolium/formazan assay to measure viability and proliferation of lymphokine-dependent cell lines. J. Immunol. Methods. 157:1993;233-240.
30. Wong J.K., Kennedy P.R., Belcher S.M. Simplified serum- and steroid-free culture conditions for high-throughput viability analysis of primary cultures of cerebellar granule neurons. J. Neurosci. Methods. 110:2001;45-55.
31. Metz S.A., Rabaglia M.E., Pintar T.J. Selective inhibitors of GTP synthesis impede exocytotic insulin release from intact rat islets. J. Biol. Chem. 267:1992;12517-12527.
32. Meredith M., Li G., Metz S.A. GTP depletion impedes calcium-induced insulin secretion from intact HIT-T15 or INS-1 β cells. Biochem. Pharmacol. 53:1997;1873-1882.
33. 2+ levels in insulin-secreting cells. Biochem. Pharmacol. 59:2000;545-556.
34. Tsai Y.H., Lai W.F., Wu Y.W., Johnson L.R. Two distinct classes of rat intestinal mucosal enzymes incorporating putrescine into protein. FEBS Lett. 435:1998;251-256.
35. Gamen S., Anel A., Lasierra P., Alava M.A., Martinez-Lorenzo M.J., Pineiro A., Naval J. Doxorubicin-induced apoptosis in human T-cell leukemia is mediated by caspase-3 activation in a Fas-independent way. FEBS Lett. 417:1997;360-364.
36. Bras A., Ruiz-Vela A., Gonzalez dB., Martinez A. Caspase activation by BCR cross-linking in immature B cells: differential effects on growth arrest and apoptosis. FASEB J. 13:1999;931-944.
37. Talanian R.V., Quinlan C., Trautz S., Hackett M.C., Mankovich J.A., Banach D., Ghayur T., Brady K.D., Wong W.W. Substrate specificities of caspase family proteases. J. Biol. Chem. 272:1997;9677-9682.
38. Sidi Y., Mitchell B.S. 2′-Deoxyguanosine toxicity for B and mature T lymphoid cell lines is mediated by guanine ribonucleotide accumulation. J. Clin. Invest. 74:1984;1640-1648.
39. Allison A.C., Eugui E.M. Mycophenolate mofetil and its mechanisms of action. Immunopharmacology. 47:2000;85-118.
40. Laliberte J., Yee A., Xiong Y., Mitchell B.S. Effects of guanine nucleotide depletion on cell cycle progression in human T lymphocytes. Blood. 91:1998;2896-2904.
41. Trejo-Skalli A.V., Velasco P.T., Murthy S.N., Lorand L., Goldman R.D. Association of a transglutaminase-related antigen with intermediate filaments. Proc. Natl. Acad. Sci. U.S.A. 92:1995;8940-8944.
42. Gentile V., Thomazy V., Piacentini M., Fesus L., Davies P.J. Expression of tissue transglutaminase in Balb-C 3T3 fibroblasts: effects on cellular morphology and adhesion. J. Cell Biol. 119:1992;463-474.
43. Knight C.R., Rees R.C., Platts A., Johnson T., Griffin M. Interleukin-2-activated human effector lymphocytes mediate cytotoxicity by inducing apoptosis in human leukaemia and solid tumour target cells. Immunology. 79:1993;535-541.
44. Ritter S.J., Davies P.J. Identification of a transforming growth factor-beta1/bone morphogenetic protein 4 (TGF-beta1/BMP4) response element within the mouse tissue transglutaminase gene promoter. J. Biol. Chem. 273:1998;12798-12806.
45. Furuya Y., Lundmo P., Short A.D., Gill D.L., Isaacs J.T. The role of calcium, pH, and cell proliferation in the programmed (apoptotic) death of androgen-independent prostatic cancer cells induced by thapsigargin. Cancer Res. 54:1994;6167-6175.
46. Paraskevas S., Maysinger D., Wang R., Duguid T.P., Rosenberg L. Cell loss in isolated human islets occurs by apoptosis. Pancreas. 20:2000;270-276.
47. Ou H., Haendeler J., Aebly M.R., Kelly L.A., Cholewa B.C., Koike G., Kwitek-Black A., Jacob H.J., Berk B.C., Miano J.M. Retinoic acid-induced tissue transglutaminase and apoptosis in vascular smooth muscle cells. Circ. Res. 87:2000;881-887.
48. Oliverio S., Amendola A., Rodolfo C., Spinedi A., Piacentini M. Inhibition of "tissue" transglutaminase increases cell survival by preventing apoptosis. J. Biol. Chem. 274:1999;34123-34128.
49. Ozeki A., Tsukamoto I. Retinoic acid repressed the expression of c-fos and c-jun and induced apoptosis in regenerating rat liver after partial hepatectomy. Biochim. Biophys. Acta. 1450:1999;308-319.
50. Piacentini M., Fesus L., Melino G. Multiple cell cycle access to the apoptotic death programme in human neuroblastoma cells. FEBS Lett. 320:1993;150-154.
51. Nagy L., Saydak M., Shipley N., Lu S., Basilion J.P., Yan Z.H., Syka P., Chandraratna R.A., Stein J.P., Heyman R.A., Davies P.J. Identification and characterization of a versatile retinoid response element (retinoic acid receptor response element-retinoid X receptor response element) in the mouse tissue transglutaminase gene promoter. J. Biol. Chem. 271:1996;4355-4365.
52. Melino G., Annicchiarico-Petruzzelli M., Piredda L., Candi E., Gentile V., Davies P.J., Piacentini M. Tissue transglutaminase and apoptosis: sense and antisense transfection studies with human neuroblastoma cells. Mol. Cell Biol. 14:1994;6584-6596.
53. Korner G., Deutsch V.R., Vlodavsky I., Eldor A. Effects of ionizing irradiation on endothelial cell transglutaminase. FEBS Lett. 330:1993;41-45.
54. Holmes F.E., Haynes L.W. Superactivation of transglutaminase type 2 without change in enzyme level occurs during progressive neurodegeneration in the mnd mouse mutant. Neurosci. Lett. 213:1996;185-188.
55. Igarashi S., Koide R., Shimohata T., Yamada M., Hayashi Y., Takano H., Date H., Oyake M., Sato T., Sato A., Egawa S., Ikeuchi T., Tanaka H., Nakano R., Tanaka K., Hozumi I., Inuzuka T., Takahashi H., Tsuji S. Suppression of aggregate formation and apoptosis by transglutaminase inhibitors in cells expressing truncated DRPLA protein with an expanded polyglutamine stretch. Nat. Genet. 18:1998;111-117.
56. Fau D., Lekehal M., Farrell G., Moreau A., Moulis C., Feldmann G., Haouzi D., Pessayre D. Diterpenoids from germander, an herbal medicine, induce apoptosis in isolated rat hepatocytes. Gastroenterology. 113:1997;1334-1346.
57. Zhang H., Koty P.P., Mayotte J., Levitt M.L. Induction of multiple programmed cell death pathways by IFN-beta in human non-small-cell lung cancer cell lines. Exp. Cell Res. 247:1999;133-141.
58. Fesus L., Thomazy V., Autuori F., Ceru M.P., Tarcsa E., Piacentini M. Apoptotic hepatocytes become insoluble in detergents and chaotropic agents as a result of transglutaminase action. FEBS Lett. 245:1989;150-154.
59. Piacentini M., Autuori F., Dini L., Farrace M.G., Ghibelli L., Piredda L., Fesus L. "Tissue" transglutaminase is specifically expressed in neonatal rat liver cells undergoing apoptosis upon epidermal growth factor-stimulation. Cell Tissue Res. 263:1991;227-235.
60. De Laurenzi V., Melino G. Gene disruption of tissue transglutaminase. Mol. Cell Biol. 21:2001;148-155.
61. Tucholski J., Johnson G.V. Tissue transglutaminase differentially modulates apoptosis in a stimuli-dependent manner. J. Neurochem. 81:2002;780-791.
62. Piredda L., Farrace M.G., Lo B.M., Malorni W., Melino G., Petruzzelli R., Piacentini M. Identification of 'tissue' transglutaminase binding proteins in neural cells committed to apoptosis. FASEB J. 13:1999;355-364.
63. Fabbi M., Marimpietri D., Martini S., Brancolini C., Amoresano A., Scaloni A., Bargellesi A., Cosulich E. Tissue transglutaminase is a caspase substrate during apoptosis. Cleavage causes loss of transamidating function and is a biochemical marker of caspase 3 activation. Cell Death Differ. 6:1999;992-1001.
64. Johnson T.S., Scholfield C.I., Parry J., Griffin M. Induction of tissue transglutaminase by dexamethasone: its correlation to receptor number and transglutaminase-mediated cell death in a series of malignant hamster fibrosarcomas. Biochem. J. 331:1998;105-112.
65. Virag L., Szabo C. BCL-2 protects peroxynitrite-treated thymocytes from poly(ADP-ribose) synthase (PARS)-independent apoptotic but not from PARS-mediated necrotic cell death. Free Radic. Biol. Med. 29:2000;704-713.
66. Szondy Z., Molnar P., Nemes Z., Boyiadzis M., Kedei N., Toth R., Fesus L. Differential expression of tissue transglutaminase during in vivo apoptosis of thymocytes induced via distinct signalling pathways. FEBS Lett. 404:1997;307-313.